Thomas Soloway

Overview

Thomas Soloway received an average of $1M in total compensation, including $379K in salary, at Audentes Therapeutics from 2016 to 2018.

Source: SEC filing on April 26, 2019.

Related executives

We found five more executives who work or worked at Audentes Therapeutics.

Natalie Holles

Audentes Therapeutics

Chief Operating Officer

Matthew Patterson

Audentes Therapeutics

Chief Executive Officer

Suyash Prasad

Audentes Therapeutics

Chief Medical Officer

John Gray

Audentes Therapeutics

Chief Technology Officer

Tom Soloway

Audentes Therapeutics

Chief Financial Officer

News

You may also like